Assessment of mimicking by EBV-CMV immunoglobulin M of anti-HLA antibodies

CONCLUSION: Cross-reactivity may occur between anti-CMV and anti-EBV IgM antibodies with HLA molecules. Thus, in graft recipients, pathogenic IgMs can also act as de novo anti-HLA antibodies and aggravate the rejection process.PMID:37865308 | DOI:10.1016/j.jim.2023.113577

Source: Journal of Immunological Methods - October 21, 2023 Category: Allergy & Immunology Authors: Rasime Derya G üleç Fatma Demet Arslan Berk Özyılmaz Nisel Y ılmaz Sevgi Y ılmaz Hancı Şükran Köse Source Type: research